115 related articles for article (PubMed ID: 35319368)
21. Improvement of Thermosensitive Liposome Stability by Cerasome Forming Lipid with Si-O-Si Network Structure.
Su Q; Pu X; Bai H; Chen X; Liao X; Huang Z; Yin G
Curr Drug Deliv; 2018; 15(4):585-593. PubMed ID: 28721817
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
23. Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).
Smith B; Lyakhov I; Loomis K; Needle D; Baxa U; Yavlovich A; Capala J; Blumenthal R; Puri A
J Control Release; 2011 Jul; 153(2):187-94. PubMed ID: 21501640
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia.
Dicheva BM; Seynhaeve AL; Soulie T; Eggermont AM; Ten Hagen TL; Koning GA
Pharm Res; 2016 Mar; 33(3):627-38. PubMed ID: 26518763
[TBL] [Abstract][Full Text] [Related]
25.
Maswadeh H; Khan A; Alorainy MS; Al-Wabel NA; Demetzos C
Drug Dev Ind Pharm; 2022 Apr; 48(4):158-168. PubMed ID: 35834369
[TBL] [Abstract][Full Text] [Related]
26. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
[No Abstract] [Full Text] [Related]
27. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
28. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
Yang B
Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
[TBL] [Abstract][Full Text] [Related]
29. Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer.
Ninomiya K; Yamashita T; Kawabata S; Shimizu N
Ultrason Sonochem; 2014 Jul; 21(4):1482-8. PubMed ID: 24418100
[TBL] [Abstract][Full Text] [Related]
30. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
31. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
32. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks.
Gaber MH; Wu NZ; Hong K; Huang SK; Dewhirst MW; Papahadjopoulos D
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1177-87. PubMed ID: 8985041
[TBL] [Abstract][Full Text] [Related]
33. Selecting ideal drugs for encapsulation in thermosensitive liposomes and other triggered nanoparticles.
Ramajayam KK; Newton DA; Haemmerich D
Int J Hyperthermia; 2022; 39(1):998-1009. PubMed ID: 35876089
[TBL] [Abstract][Full Text] [Related]
34. Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model.
Sebeke LC; Castillo Gómez JD; Heijman E; Rademann P; Simon AC; Ekdawi S; Vlachakis S; Toker D; Mink BL; Schubert-Quecke C; Yeo SY; Schmidt P; Lucas C; Brodesser S; Hossann M; Lindner LH; Grüll H
J Control Release; 2022 Mar; 343():798-812. PubMed ID: 35134460
[TBL] [Abstract][Full Text] [Related]
35. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
[TBL] [Abstract][Full Text] [Related]
36. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
37. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With
Santos MA; Goertz DE; Hynynen K
Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458
[TBL] [Abstract][Full Text] [Related]
38. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
39. Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine.
Regenold M; Kaneko K; Wang X; Peng HB; Evans JC; Bannigan P; Allen C
J Control Release; 2023 Feb; 354():19-33. PubMed ID: 36503069
[TBL] [Abstract][Full Text] [Related]
40. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.
Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS
Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
